132 related articles for article (PubMed ID: 6544119)
21. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
23. Parenchymal damage in the territory of the anterior choroidal artery following supraophthalmic intracarotid administration of CDDP for treatment of malignant gliomas.
Tamaki M; Ohno K; Niimi Y; Aoyagi M; Nagashima G; Ichimura K; Hirakawa K
J Neurooncol; 1997 Oct; 35(1):65-72. PubMed ID: 9266442
[TBL] [Abstract][Full Text] [Related]
24. Intracarotid cisplatin-based chemotherapy in patients with malignant melanoma and central nervous system (CNS) metastases.
Feun LG; Lee YY; Plager C; Papadopoulos N; Savaraj N; Charnsangavej C; Benjamin RS; Wallace S
Am J Clin Oncol; 1990 Oct; 13(5):448-51. PubMed ID: 1699402
[TBL] [Abstract][Full Text] [Related]
25. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
[TBL] [Abstract][Full Text] [Related]
26. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
Follézou JY; Fauchon F; Chiras J
Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
[TBL] [Abstract][Full Text] [Related]
27. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
[TBL] [Abstract][Full Text] [Related]
28. Intracarotid cisplatin chemotherapy for high-grade astrocytomas.
Brambilla Bas M; Boccardo M
J Neurosurg Sci; 1993 Jun; 37(2):83-6. PubMed ID: 8301375
[TBL] [Abstract][Full Text] [Related]
29. Visual system toxicity following intra-arterial chemotherapy.
Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
[TBL] [Abstract][Full Text] [Related]
30. Intraarterial association of cis-platinum and bleomycin in head and neck cancer.
Galmarini FC; Yoel J; Nakasone J; Molina CM
Auris Nasus Larynx; 1985; 12 Suppl 2():S234-8. PubMed ID: 2425788
[TBL] [Abstract][Full Text] [Related]
31. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
32. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas.
Vance RB; Pittisapu J; Kapp JP
J Neurooncol; 1986; 4(2):151-4. PubMed ID: 3783209
[TBL] [Abstract][Full Text] [Related]
33. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
Madajewicz S; Chowhan N; Tfayli A; Roque C; Meek A; Davis R; Wolf W; Cabahug C; Roche P; Manzione J; Iliya A; Shady M; Hentschel P; Atkins H; Braun A
Cancer; 2000 May; 88(10):2350-6. PubMed ID: 10820358
[TBL] [Abstract][Full Text] [Related]
34. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
35. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
Madajewicz S; Chowhan N; Iliya A; Roque C; Beaton R; Davis R; Fertman S; Meek A; Alvarez O; Pampati M
Cancer; 1991 Jun; 67(11):2844-9. PubMed ID: 1851050
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.
Doolittle ND; Miner ME; Hall WA; Siegal T; Jerome E; Osztie E; McAllister LD; Bubalo JS; Kraemer DF; Fortin D; Nixon R; Muldoon LL; Neuwelt EA
Cancer; 2000 Feb; 88(3):637-47. PubMed ID: 10649259
[TBL] [Abstract][Full Text] [Related]
37. Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience.
Korogi Y; Hirai T; Nishimura R; Hamatake S; Sakamoto Y; Murakami R; Baba Y; Arakawa A; Takahashi M; Uji Y
AJR Am J Roentgenol; 1995 Nov; 165(5):1269-72. PubMed ID: 7572516
[TBL] [Abstract][Full Text] [Related]
38. Intraarterial mitomycin-C for recurrent brain metastases.
Stewart DJ; Grahovac Z; Hugenholtz H; Russell NA; Richard MT; Benoit BG; Riding MD; Danjoux C; Maroun JA
Am J Clin Oncol; 1987 Oct; 10(5):432-6. PubMed ID: 2444094
[TBL] [Abstract][Full Text] [Related]
39. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.
Mahaley MS; Whaley RA; Blue M; Bertsch L
J Neurooncol; 1986; 3(4):297-314. PubMed ID: 3958776
[TBL] [Abstract][Full Text] [Related]
40. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
